Experimental Drug Shows Promise in Lowering Cholesterol, Heart Attack Risk
Adding the ‘investigational biologic’ evolocumab to statin therapy works better, study saysContinue Reading
Adding the ‘investigational biologic’ evolocumab to statin therapy works better, study saysContinue Reading
Study found they changed treatments, lowered chances of later heart attack than standard careContinue Reading
CT may slightly outperform ‘functional’ tests because it helps rule out unnecessary procedures, researchers sayContinue Reading
Company-funded trial finds lower rates of heart attack, death with Brilinta versus placeboContinue Reading
People with hypertrophic cardiomyopathy are benefiting from defibrillators, other advancesContinue Reading
Gene change allows some people in Andean region to metabolize the toxic chemical, study saysContinue Reading
More than 16 million Americans have incurable skin conditionContinue Reading
More than 16 million Americans have incurable skin conditionContinue Reading
Dire need for low-cost dialysis techniques that could be used worldwide, researcher saysContinue Reading
Experts note full recovery generally takes six weeks or lessContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.